Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ADCT


Fundamental

Company: Adc Therapeutics SA
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Exchange: NYSE
Index: RUT
P/E: -
EPS (ttm): -1.57
Insider Own: 21.65%
Shs Outstand: 112.50M
Perf Week: 4.84%
Market Cap: 365.62M
Forward P/E: -
EPS next Y: -1.31
Insider Trans: 0.00%
Shs Float: 88.15M
Perf Month: 10.54%
Enterprise Value: 551.83M
PEG: -
EPS next Q: -0.35
Inst Own: 59.29%
Short Float: 5.12%
Perf Quarter: 17.33%
Income: -169.94M
P/S: 4.73
EPS this Y: 6.42%
Inst Trans: 69.91%
Short Ratio: 5.65
Perf Half Y: 105.70%
Sales: 77.25M
P/B: -
EPS next Y Percentage: 13.72%
ROA: -49.02%
Short Interest: 4.51M
Perf YTD: 63.32%
Book/sh: -1.77
P/C: 1.38
EPS next 5Y: 17.43%
ROE: -
52W High: 3.97 -18.14%
Perf Year: -0.31%
Cash/sh: 2.35
P/FCF: -
EPS past 3/5Y: 18.47% 1.38%
ROIC: -68.03%
52W Low: 1.05 209.52%
Perf 3Y: -58.01%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: 27.82% 97.79%
Gross Margin: 89.18%
Volatility W: 4.45%
Volatility M: 5.78%
Perf 5Y: -92.36%
Dividend TTM: -
EV/Sales: 7.14
EPS Y/Y TTM: 38.73%
Oper. Margin: -165.08%
ATR (14): 0.17
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 4.66
Sales Y/Y TTM: 15.73%
Profit Margin: -220.00%
RSI (14): 59.38
Recom: 1.00
Dividend Gr. 3/5Y: - -
Current Ratio: 4.93
EPS Q/Q: -30.40%
SMA20: 8.99%
Beta: 2.02
Target Price: 8.25
Payout: -
Debt/Eq: -
Sales Q/Q: 8.21%
SMA50: 9.27%
Rel Volume: 0.90
Prev Close: 3.22
Employees: 265
LT Debt/Eq: -
Earnings: Aug 12 BMO
SMA200: 47.36%
Avg Volume: 798.37K
Price: 3.25
IPO: May 15, 2020
Option/Short: Yes / Yes
EPS/Sales Surpr.: -1.63% 5.48%
Trades:
Volume: 724,446
Change: 0.93%

Technical:


Latest News:

Cullinan stock rises on Amgen's Blincyto data (NASDAQ:CGEM) | Seeking Alpha very bullish
CGEM AMGN ADCT ALLO AZN AUTL BMY IPSC GILD MOR NKTX NVS

Summary: Cullinan Therapeutics (CGEM) stock surged ~58% last week after positive data for CD19-targeting therapy similar to competitor Amgen's Blincyto, showing efficacy against autoimmune diseases like rheumatoid arthritis and systemic sclerosis.

Full article
2024-04-27T19:44:12Z